Asian Spectator


The Times

.

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

  • Written by PR Newswire Asia - Asian Spectator

SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief Scientific Officer (CSO).

Dr. Rao is the scientific originator of the epigenetic framework underlying paxalisib...

Magazine

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

Why Early Protection of Intellectual Assets is Critical

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

Konservasi gaya lama tak efektif: Pemulihan Aceh perlu warga dengan ekonomi yang merawat hutan

shutterstock(Manthofana/Shutterstock)● Peminggiran warga dari konservasi hutan Lingga Isaq menjadi salah satu faktor yang memperparah dampak bencana.● Pertanian monokultur dan tambang emas...

hacklink hack forum hacklink film izle hacklink sahabetz-libraryİnterbahisTaraftarium24GrandpashabetcasibomjojobetHoliganbetgrandpashabetDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026İnterbahisjojobet giriş爱思助手下载jojobetjojobetjojobetjojobetjojobetjojobetjojobetjojobetholiganbet giriştelegram下载jojobet girişGrandpashabet yasal mıGrandpashabetbetpark有道翻译下载jojobetjojobetJojobetgrandpashabetjojobet